Description
NicloMed™ Is a registered trademark of Right2Try Inc and defined as Niclosamide and it’s investigations into repurposed usage as:
- A chemical that Inhibits the growth and metastasis of malignant cells in the body.
- Enhances the responsiveness of malignant cells to chemotherapeutic agents.
- Targets mTOR, STAT3, NF-KB and Notch pathways.
- Enhances ROS-activated and JNK-mediated apoptosis in cells subjected to glucose deprivation.
Right2Try Inc.™ is a company that upholds the rights of patients with terminal diagnoses to choose alternative treatment options under the Right to Try Act of 2017.
For experimental use and research purposes only.
Ingredients: Niclosamide, Cornstarch, Dextrin, Magnesium Sterate
DISCLAIMER
Right2Try Inc products are furnished for LABORATORY RESEARCH USE ONLY. This product should only be handled by qualified, and licensed professionals. All information on this website is available for educational purposes only.
*Research chemicals are chemical substances used by scientists for medical and scientific research purposes. One characteristic of a research chemical is that it is for laboratory research use only; a research chemical is not intended for human or veterinary use. This distinction is required on the labels of research chemicals, and is what exempts them from regulation under parts 100-740 in Title 21 of the Code of Federal Regulations (21CFR).
